Polymer dots enable deep in vivo multiphoton fluorescence imaging of cerebrovascular
architecture
Hassan, Ahmed M.; Wu, Xu; Jarrett, Jeremy W.; Xu, Shihan; Miller, David R.; Yu, Jiangbo; Perillo, Evan P.; Liu, Yen-Liang; Chiu, Daniel T.; Yeh, Hsin-Chih; Dunn, Andrew K.
Angol nyelvű Konferenciaközlemény (Könyvrészlet) Tudományos
Deep in vivo imaging of vasculature requires small, bright, and photostable fluorophores
suitable for multiphoton microscopy (MPM). Although semiconducting polymer dots (pdots)
are an emerging class of highly fluorescent contrast agents with favorable advantages
for the next generation of in vivo imaging, their use for deep multiphoton imaging
has never before been demonstrated. Here we characterize the multiphoton properties
of three pdot variants (CNPPV, PFBT, and PFPV) and demonstrate deep imaging of cortical
microvasculature in C57 mice. Specifically, we measure the two-versus three-photon
power dependence of these pdots and observe a clear three-photon excitation signature
at wavelengths longer than 1300 nm, and a transition from two-photon to three-photon
excitation within a 1060 - 1300 nm excitation range. Furthermore, we show that pdots
enable in vivo two-photon imaging of cerebrovascular architecture in mice up to 850
mu m beneath the pial surface using 800 nm excitation. In contrast with traditional
multiphoton probes, we also demonstrate that the broad multiphoton absorption spectrum
of pdots permits imaging at longer wavelengths (lambda(ex) = 1,060 and 1225 nm). These
wavelengths approach an ideal biological imaging wavelength near 1,300 nm and confer
compatibility with a high-power ytterbium-fiber laser and a high pulse energy optical
parametric amplifier, resulting in substantial improvements in signal-to-background
ratio (>3.5-fold) and greater cortical imaging depths of 900 mu m and 1300 mu m. Ultimately,
pdots are a versatile tool for MPM due to their extraordinary brightness and broad
absorption, which will undoubtedly unlock the ability to interrogate deep structures
in vivo.